权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Phosphate signaling in biomineralization

生物矿化中的磷酸盐信号传导

基本信息

批准号：
10177871
负责人：
Dobrawa Napierala
金额：
$ 32.99万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-01 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10177871
关键词：
Affect Agonist Binding Blood Vessels Calcium Cartilage Cell Line Cell physiology Cells Chronic Complex Cyclic AMP Cyclic AMP-Dependent Protein Kinases Data Defect Dental Dentin Development Diagnosis Disease Extracellular Matrix Extracellular Signal Regulated Kinases Fluorescence Resonance Energy Transfer Foundations Gene Expression Genes Genetic Genetic Transcription Goals Homeostasis Hypophosphatasia Hypophosphatemia Image Impairment In Vitro Isoenzymes Knockout Mice Knowledge Life MAPK3 gene Measures Mediating Mediator of activation protein Minerals Molecular Molecular Target Mus Mutate Odontoblasts Osteoblasts PTH gene Pathologic Pathway interactions Pharmacology Phosphotransferases Physiological Physiology Process Protein Kinase C Receptor Signaling Role Signal Pathway Signal Transduction Signaling Molecule Spectroscopy, Fourier Transform Infrared Testing Tissues Vesicle base biomineralization bone cell growth regulation conditional knockout extracellular in vivo inhibitor/antagonist inorganic phosphate live cell imaging microCT mineralization novel osteogenic parathyroid hormone-related protein progenitor receptor response skeletal small molecule inhibitor targeted treatment therapeutic target

项目摘要

Abstract Inorganic phosphate (PO43-/Pi) is a critical regulator of the physiologic biomineralization process in skeletal and dental tissues, and is a major contributing factor to pathologic mineralization of blood vessels. The central role of Pi in biomineralization is underscored by a broad-range of mineralization defects in genetic and acquired disorders affecting systemic Pi homeostasis (hyperphosphatemia and hypophosphatemia) and local/cellular Pi availability (e.g. hypophosphatasia). Although it is well established now that Pi is a signaling molecule that can change cellular physiology, the underlying molecular mechanisms by which Pi executes this function remain largely unknown. This gap in our knowledge impedes development of targeted therapeutic approaches to diseases caused by abnormal Pi availability. Our goal is to delineate the signaling cascade that regulates biomineralization in response to extracellular Pi. We and others have shown that molecular interactions upstream of Erk1/2 kinase are central to initiating the response to extracellular Pi in the majority of analyzed cells. Our preliminary studies in cells producing mineralized extracellular matrix (osteogenic cells) identified a molecular circuit, which is required for activation of Erk1/2 and mineralization-supporting functions in response to Pi. First, our in vitro data show that osteogenic cells deficient in parathyroid hormone/parathyroid hormone related protein receptor 1 (Pth1r) do not activate Erk1/2 under high Pi conditions and have significantly impaired transcriptional response to Pi. Second, our data suggest that Pi-induced Erk1/2 activation and gene expression are dependent on the protein kinase C (PKC). Furthermore, our data suggest that the cellular response to Pi is enhanced by calcium (Ca2+). Based on these data we hypothesize that the Pi-induced signaling cascade is integrated with the Pth1r-PKC-Erk1/2 pathway in osteogenic cells. To test this hypothesis we will use in vitro and in vivo approaches focused on signaling in cells producing mineralized extracellular matrix. In the Aim 1 of this project, we will define the molecular circuit of Pth1r-dependent activation of cellular responses to Pi. In the Aim 2, we will determine the functional role of Pth1r in Pi signaling and Pi-regulated mineralization in vivo. In the Aim 3, we will determine the role of Ca2+ in mineralization-supporting functions of Pi signaling. By completing these Aims, will provide the first characterization of the Pi-induced signaling cascade and identify molecular players required for initiation of cellular responses to Pi in osteogenic cells. This will provide the foundation for identification of targets for pharmacological regulation of cellular sensitivity to available Pi.

摘要